雜志介紹

Neurosciences雜志介紹

《Neurosciences》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱神經(jīng)科學(xué)，本刊主要出版、報(bào)道醫(yī)學(xué)-CLINICAL NEUROLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.2，最新CiteScore 指數(shù)為1.4。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• The clinicopathological features and prognosis of multifocal high-grade gliomas in adults with H3F3A mutation

  Author: Zhao, Yongrui; Chen, Yidong; Wang, Leiming; Gao, Ying; Xu, Jiankun

• Changes in routine blood parameters of patients with generalized tonic clonic seizure: a retrospective study

  Author: Huang, Jiankang; Yang, Jun; Miao, Jiali; Wen, Hongbo

• Impact of operation details on hydrocephalus after decompressive craniectomy.

  Author: Wang QP, Ma JP, Zhou ZM, You C.

• Response to rituximab in an anti-muscle-specific receptor tyrosine kinase- and anti-acetylcholine recepto-double-positive myasthenia gravis patient concomitant with follicular dendritic cell sarcoma.

  Author: Wang J, Wu X, Deng H, Liu Y, Liu H, Fan X, Liu K, Wu J, Zhang HL.

英文介紹

Neurosciences雜志英文介紹

Neurosciences is an open access, peer-reviewed, quarterly publication. Authors are invited to submit for publication articles reporting original work related to the nervous system, e.g., neurology, neurophysiology, neuroradiology, neurosurgery, neurorehabilitation, neurooncology, neuropsychiatry, and neurogenetics, etc. Basic research withclear clinical implications will also be considered. Review articles of current interest and high standard are welcomed for consideration. Prospective workshould not be backdated. There are also sections for Case Reports, Brief Communication, Correspondence, and medical news items. To promote continuous education, training, and learning, we include Clinical Images and MCQ’s. Highlights of international and regional meetings of interest, and specialized supplements will also be considered. All submissions must conform to the Uniform Requirements.